Hamza Ansari, MD

09/02/2014

Despite high-risk percutaneous coronary intervention (PCI) with early revascularization, no significant improvement in the rates of cardiogenic shock post-ST-elevation myocardial infarction (STEMI) has been seen.

Despite high-risk percutaneous...

09/02/2014

Cath Lab Digest

Percutaneous Support with TandemHeart Device for Post Myocardial Infarction Ventriculoseptal Rupture and Cardiogenic Shock: A New Treatment Paradigm?

01/31/2014

Hamza Ansari , MD;

We describe here a case of a man who developed ventriculoseptal rupture with cardiogenic shock after a large myocardial infarction and later received hemodynamic support with a TandemHeart assist device, allowing myocardial recovery and...

We describe here a case of a man...

01/31/2014

Cath Lab Digest

Clinical Update

Intracoronary Plaque Assessment Using Near-Infrared Spectroscopy Technology: A Valuable Tool?

10/02/2017

Hamza Ansari , MD;

Islam Bolad , MD;

NIRS can help determine the distribution and chemical composition of underlying plaque, and allows for the identification of vulnerable plaques.

NIRS can help determine the...

10/02/2017

Cath Lab Digest

Commentary

Retrograde CTO-PCI Through Vein Grafts: Come on Down!

05/27/2016

Anas Alomar , MD;

Hamza Ansari , MD;

Jeffrey A. Breall , MD, PhD;

CTO-PCI success rates still do not approach those of conventional PCIs despite the available options; more robust data are required in the form of randomized trials before CTO-PCI becomes commonplace.

CTO-PCI success rates still do...

05/27/2016

Journal of Invasive Cardiology